Safety and efficacy of a dose-dense short-term therapy in patients with MYC-translocated aggressive lymphoma.
Ferreri AJM, Angelillo P, Erbella F, Cattaneo C, Verga L, Lleshi A, Allione B, Ponzoni M, Facchetti F, Pagani C, Foppoli M, Pecciarini L, Sassone M, Steffanoni S, Flospergher E, Rossi G, Spina M, Re A.
Ferreri AJM, et al. Among authors: rossi g.
Blood Adv. 2022 Nov 22;6(22):5811-5820. doi: 10.1182/bloodadvances.2022007475.
Blood Adv. 2022.
PMID: 35580327
Free PMC article.